Literature DB >> 11183022

The management of depression: the implications for managed care--roundtable discussion: Part 3.

M Vodoor, Y P Southwell, M Grubin, S Wert, L Kang-Cipolla, A Denes, S Evans, J Mason, M Zarr, L Osborn, J Kenney, E Hunkeler, W Waugh, S Bull.   

Abstract

From the standpoint of managed care, the rising cost of depression can be addressed in multiple ways. In the final portion of the roundtable discussion, the faculty discuss not only disease management programs for depression, but other initiatives health plans (including at the pharmacy level) are undertaking to address the rising costs associated with depression. They also discuss the effect of mental health coverage "parity" laws, which can be expected to drive costs even higher.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11183022

Source DB:  PubMed          Journal:  Manag Care Interface        ISSN: 1096-5645


  1 in total

1.  Reducing drug costs at a Veterans Affairs hospital by increasing market-share of generic fluoxetine.

Authors:  Steven K Dobscha; Lisa M Winterbottom; Leann S Snodgrass
Journal:  Community Ment Health J       Date:  2006-09-22
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.